S. Eerikäinen
- Molecular Biology
- Cellular and Molecular Neuroscience top 10%
- Developmental Neuroscience top 5%
- Surgery
- Genetics
- Co-authors
- Matti S. AiraksinenKai SavolainenJonne NaaralaJarkko LoikkanenRaimo K. TuominenUrmas ArumäeJari RossiDmitry Poteryaev
- Topics
- Drug Solubulity and Delivery Systems (3 papers)Advancements in Transdermal Drug Delivery (2 papers)Neuroscience and Neuropharmacology Research (2 papers)
In The Last Decade
S. Eerikäinen
11 papers receiving 403 citations
Peers
Comparison fields: 5 of 73
- Molecular Biology 196
- Cellular and Molecular Neuroscience 157
- Developmental Neuroscience 78
- Surgery 72
- Genetics 42
Countries citing papers authored by S. Eerikäinen
This map shows the geographic impact of S. Eerikäinen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Eerikäinen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Eerikäinen more than expected).
Fields of papers citing papers by S. Eerikäinen
This network shows the impact of papers produced by S. Eerikäinen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Eerikäinen. The network helps show where S. Eerikäinen may publish in the future.
Co-authorship network of co-authors of S. Eerikäinen
This figure shows the co-authorship network connecting the top 25 collaborators of S. Eerikäinen. A scholar is included among the top collaborators of S. Eerikäinen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Eerikäinen. S. Eerikäinen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Bioavailability of metoclopramide from orally and rectally administered novel hydroxypropyl methylcellulose capsules containing different diluents: a comparison with corresponding gelatine capsules | 5 |
| 2 | 27 | |
| 3 | 46 | |
| 4 | 229 | |
| 5 | 52 | |
| 6 | Glutamate-stimulated ROS production in neuronal cultures: interactions with lead and the cholinergic system. | 38 |
| 7 | 1 | |
| 8 | 6 | |
| 9 | 5 | |
| 10 | 4 | |
| 11 | 5 |
About S. Eerikäinen
S. Eerikäinen is a scholar working on Pharmaceutical Science, Surfaces, Coatings and Films and Nutrition and Dietetics, having authored 11 papers that have together received 418 indexed citations. Recurring topics across this work include Drug Solubulity and Delivery Systems (3 papers), Advancements in Transdermal Drug Delivery (2 papers) and Neuroscience and Neuropharmacology Research (2 papers). The work is most often cited by research in Developmental Neuroscience (78 citations), Cellular and Molecular Neuroscience (157 citations) and Gastroenterology (30 citations). S. Eerikäinen has collaborated with scholars based in Finland and Germany. Frequent co-authors include Matti S. Airaksinen, Kai Savolainen, Jonne Naarala, Jarkko Loikkanen, Raimo K. Tuominen, Urmas Arumäe, Jari Rossi, Dmitry Poteryaev, Merja Lakso and Heikki Rauvala. Their work appears in journals such as Neuron, Genome Research and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.